MedPage Today (4/21, Minerd ) reports on a study finding that “daily oral and monthly extended-releaseinjectable naltrexone were similarly effective at reducing heavy drinking days in patients with alcohol use disorder (AUD).” The study included “248 adults prescribed treatment at hospital discharge, the mean percentage of heavy drinking days decreased from 66.7% at baseline to 27.4% at 3 months in the oral naltrexone group and from 70.7% to 23.8% in the extended-release injectable naltrexone group.” The findingswere published in JAMA Internal Medicine.
Related Links:
— MedPage Today (requires login and subscription)